|
|
Your search for: 'Diabetes*' |
Documents 411 - 420 of 460 matches |
|
411. (Journal Article): Polyclonal Anti-T-Cell Therapy for Type 1 Diabetes Mellitus of Recent Onset
Saudek F, Havrdova T, Boucek P, Karasova L, Novota P, Skibova J ABSTRACT:
The destruction of pancreatic beta-cells in type 1 diabetes mellitus is mediated by autoreactive T-lymphocyte clones. We initiated a prospective randomized controlled trial of poly...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T1DM
»
Re-establishing Tole...
»
Modifying Immunity
»
Recent Onset
»
Site-Specific Interv...
»
Journal Article
submitted: Oct 03, 2006 |
|
412. (Journal Article): Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S, Giarratana N, Smiroldo S, Adorini L ABSTRACT:
In the nonobese diabetic (NOD) mouse, pathogenic and suppressor CD4(+) T cells can be distinguished by the constitutive expression of CD25. In this study, we demonstrate that the p...
|
»
Diabetes OD
»
Development and Func...
»
Immune System
»
Activation and Inhib...
»
Journal Article
submitted: May 26, 2005 |
|
413. (Journal Article): Global and societal implications of the diabetes epidemic
Zimmet P, Alberti KG, Shaw J ABSTRACT:
Changes in human behaviour and lifestyle over the last century have resulted in a dramatic increase in the incidence of diabetes worldwide. The epidemic is chiefly of type 2 diabet...
|
»
Diabetes OD
»
Diabetes Pathogenesi...
»
T2DM
»
Epidemiology
»
Journal Article
submitted: Dec 18, 2004 |
|
414. (Journal Article): Modulation of Adipoinsular Axis in Prediabetic ZDF rats by Diazoxide
Alemzadeh R, Tushaus KM ABSTRACT:
Dysregulation of the adipoinsular axis in male obese Zucker diabetic fatty (ZDF, fa/fa) rats, a model of type 2 diabetes, results in chronic hyperinsulinemia and increased de novo ...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T2DM
»
Journal Article
submitted: Aug 22, 2004 |
|
415. (Journal Article): Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality
Berton G, Cordiano R, Palmieri R, De Toni R, Guarnieri GL, Palatini P ABSTRACT:
AIMS/HYPOTHESIS. Diabetes mellitus is associated with increased mortality in subjects with acute myocardial infarction (AMI). We aimed to estimate the risk of mortality in AMI pati...
|
»
Diabetes OD
»
Diabetic Complicatio...
»
Cardiovascular
»
Myocardial Infarctio...
»
Journal Article
submitted: Feb 20, 2005 |
|
416. (Journal Article): Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.
Nauck MA, Meier JJ ABSTRACT:
Glucagon-like peptide 1 (GLP-1) was discovered as an insulinotropic gut hormone, suggesting a physiological role as an incretin hormone, i.e., being responsible, in part, for the h...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Anti-Hyperglycemic a...
»
Incretin Hormones
»
Incretin Mimetics
»
Journal Article
submitted: Nov 19, 2005 |
|
417. (Journal Article): Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.
Fineman MS, Bicsak TA, Shen LZ, Taylor K, Gaines E, Varns A, Kim D, Baron AD ABSTRACT:
OBJECTIVE: AC2993 (synthetic exendin-4; exenatide) is a peptide that enhances glucose-dependent insulin secretion, suppresses inappropriately elevated glucagon secretion, and slows...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Anti-Hyperglycemic a...
»
Incretin Hormones
»
Incretin Mimetics
»
Exenatide
»
Effectivity of Exena...
»
Effectivity after/in...
»
Journal Article
submitted: Nov 29, 2005 |
|
418. (Journal Article): The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes.
Harder H, Nielsen L, Tu DT, Astrup A ABSTRACT:
OBJECTIVE: Glucagon-like peptide (GLP)-1 is a gut hormone that exerts incretin effects and suppresses food intake in humans, but its therapeutic use is limited due to its short hal...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Anti-Hyperglycemic a...
»
Incretin Hormones
»
Incretin Mimetics
»
Liraglutide
»
Human Studies
»
Journal Article
submitted: Nov 29, 2005 |
|
419. (Journal Article): Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49).
Turner RC, Cull CA, Frighi V, Holman RR ABSTRACT:
CONTEXT: Treatment with diet alone, insulin, sulfonylurea, or metformin is known to improve glycemia in patients with type 2 diabetes mellitus, but which treatment most frequently ...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Progressive Treatmen...
»
Journal Article
submitted: Jun 17, 2005 |
|
420. (Journal Article): The Influence of Physicians' Practice Management Strategies and Financial Arrangements on Quality of Care Among Patients With Diabetes
Keating NL, Landrum MB, Landon BE, Ayanian JZ, Borbas C, Wolf R, Guadagnoli E ABSTRACT:
CONTEXT:: Health care organizations use many strategies to influence physician behavior and the care delivered, but the effect of such strategies on quality is not known. OBJECTIVE...
|
»
Diabetes OD
»
Disease Management
»
Compliance and Adher...
»
Journal Article
submitted: Aug 22, 2004 |
|
|
|
|